Subchapter IX: GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME
Part A: Genetic Diseases
- Section 300b: Repealed. Pub. L. 97–35, title XXI, § 2193(b)(1), Aug. 13, 1981, 95 Stat. 827
- Section 300b–1: Research project grants and contracts
- Section 300b–2: Voluntary participation by individuals
- Section 300b–3: Application; special consideration to prior sickle cell anemia grant recipients
- Section 300b–4: Public Health Service facilities
- Section 300b–5: Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
- Section 300b–6: Applied technology
- Section 300b–7: Tourette Syndrome
- Section 300b–8: Improved newborn and child screening for heritable disorders
- Section 300b–9: Evaluating the effectiveness of newborn and child screening and followup programs
- Section 300b–10: Advisory Committee on Heritable Disorders in Newborns and Children
- Section 300b–11: Clearinghouse of newborn screening information
- Section 300b–12: Laboratory quality and surveillance
- Section 300b–13: Interagency Coordinating Committee on Newborn and Child Screening
- Section 300b–14: National contingency plan for newborn screening
- Section 300b–15: Hunter Kelly Research Program
- Section 300b–16: Authorization of appropriations for newborn screening programs and activities
- Section 300b–17: Report by Secretary
Part B: Sudden Infant Death Syndrome
- Section 300c–11: Repealed. Pub. L. 97–35, title XXI, § 2193(b)(1), Aug. 13, 1981, 95 Stat. 827
- Section 300c–12: Sudden infant death syndrome research
- Section 300c–13: Continuing activities related to stillbirth, sudden unexpected infant death and sudden unexplained death in childhood
Part C: Hemophilia Programs
- Section 300c–21: Repealed. Pub. L. 97–35, title XXI, § 2193(b)(1), Aug. 13, 1981, 95 Stat. 827
- Section 300c–22: Blood-separation centers